Focus and Scope
Antibody Reports (ISSN 2624-8557) focuses on experimental validation of recombinant antibodies. The general aim is to define the specificity of an antibody and which detection techniques it is compatible with. Negative results, when including an adequate positive control, are also valuable. We encourage scientists to publish their experimental results in as much detail as possible, with the philosophy of "one antigen, one technique, one paper".
Open Access Policy
This journal is purely open access and provides immediate access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.
Copyright for articles published in this journal is retained by the authors, with first publication rights granted to the journal. By virtue of their appearance in this open access journal, articles are free to use after initial publication under the Creative Commons Attribution 4.0 International licence (CC-BY).
This journal is published by the Bibliothèque de l'Université de Genève on behalf of the Geneva Antibody Facility.
This journal ensures the long-term availability of its contents. Articles published in Antibody Reports are automatically deposited in the institutional repository of the University of Geneva, and from there, in the SAFE Private LOCKSS Network managed by 7 universities located on multiple continents, thus ensuring a very high level of preservation.